Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026

Calidi Biotherapeutics announced a 1-for-16 reverse stock split effective July 31, 2026, approved by stockholders on June 12, 2026. The company aims to optimize market dynamics and broaden investor appeal. Every 16 pre-split shares will consolidate into one share, with fractional shares rounded up to the nearest whole share.